Laburthe M[au] - Search Results

Year	Number of Results
1973	1
1974	2
1975	2
1977	5
1978	4
1979	6
1980	9
1981	6
1982	2
1983	5
1984	8
1985	9
1986	5
1987	4
1988	4
1989	11
1990	7
1991	6
1992	6
1993	7
1994	8
1995	3
1996	9
1997	3
1998	10
1999	2
2000	10
2001	4
2002	5
2003	6
2004	5
2006	6
2007	6
2008	8
2009	5
2010	3
2011	2
2012	7
2013	1
2021	0

1

[MicroRNAs and intestinal pathophysiology].

Ogier-Denis E, Fasseu M, Vandewalle A, Laburthe M. Ogier-Denis E, et al. Among authors: laburthe m. Med Sci (Paris). 2007 May;23(5):509-14. doi: 10.1051/medsci/2007235509. Med Sci (Paris). 2007. PMID: 17502067 Free article. Review. French.

2

VPAC receptors for VIP and PACAP.

Laburthe M, Couvineau A, Marie JC. Laburthe M, et al. Recept Channels. 2002;8(3-4):137-53. Recept Channels. 2002. PMID: 12529932 Review.

3

Receptors for gut regulatory peptides.

Laburthe M, Couvineau A, Amiranoff B, Voisin T. Laburthe M, et al. Baillieres Clin Endocrinol Metab. 1994 Jan;8(1):77-110. doi: 10.1016/s0950-351x(05)80227-7. Baillieres Clin Endocrinol Metab. 1994. PMID: 7510949 Review.

4

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.

Couvineau A, Laburthe M. Couvineau A, et al. Among authors: laburthe m. Br J Pharmacol. 2012 May;166(1):42-50. doi: 10.1111/j.1476-5381.2011.01676.x. Br J Pharmacol. 2012. PMID: 21951273 Free PMC article. Review.

5

VPAC1 receptor binding site: contribution of photoaffinity labeling approach.

Couvineau A, Ceraudo E, Tan YV, Laburthe M. Couvineau A, et al. Among authors: laburthe m. Neuropeptides. 2010 Apr;44(2):127-32. doi: 10.1016/j.npep.2009.11.008. Epub 2009 Dec 23. Neuropeptides. 2010. PMID: 20031208 Review.

6

The family B1 GPCR: structural aspects and interaction with accessory proteins.

Couvineau A, Laburthe M. Couvineau A, et al. Among authors: laburthe m. Curr Drug Targets. 2012 Jan;13(1):103-15. doi: 10.2174/138945012798868434. Curr Drug Targets. 2012. PMID: 21777182 Review.

7

Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.

Laburthe M, Couvineau A, Tan V. Laburthe M, et al. Peptides. 2007 Sep;28(9):1631-9. doi: 10.1016/j.peptides.2007.04.026. Epub 2007 May 22. Peptides. 2007. PMID: 17574305 Review.

8

Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. Harmar AJ, et al. Among authors: laburthe m. Br J Pharmacol. 2012 May;166(1):4-17. doi: 10.1111/j.1476-5381.2012.01871.x. Br J Pharmacol. 2012. PMID: 22289055 Free PMC article. Review.

9

Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.

Laburthe M, Couvineau A. Laburthe M, et al. Regul Pept. 2002 Oct 15;108(2-3):165-73. doi: 10.1016/s0167-0115(02)00099-x. Regul Pept. 2002. PMID: 12220741 Review.

10

Orexins and their receptors: structural aspects and role in peripheral tissues.

Voisin T, Rouet-Benzineb P, Reuter N, Laburthe M. Voisin T, et al. Among authors: laburthe m. Cell Mol Life Sci. 2003 Jan;60(1):72-87. doi: 10.1007/s000180300005. Cell Mol Life Sci. 2003. PMID: 12613659 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results